Oxiconazole in the treatment of tropical dermatomycoses

Rippon, 1982, Medical mycology. The pathogenic fungi and actinomycetes, 110 Gugnani, 1982, Mycoses as a public health problem in Nigeria, Niger J Microbiol, 2, 47 Clayton, 1982, Antifungal drugs Polak, 1982, Oxiconazole, a new imidazole derivative: Evaluation of antifungal activity in vitro and in vivo, Arzneim Forschung Drug Res, 32, 17 Wagner, 1987, Oxiconazole bei dermatomykosen-eindopblebinder, randomisierter therapievergleich mit bifonazol, Mykosen, 30, 484, 10.1111/j.1439-0507.1987.tb03834.x Odds, 1984, Antifungal relative inhibition factors: Bay 1-9139, bifonazole, butaconazole, isoconazole, itraconazole (CR 51211), oxiconazole, RO 14-4767/002, sulconazole, terconazole and vibunazole (Bay n7133) compared in vitro with nine established antifungal agents, J Antimicrob Chemother, 14, 105, 10.1093/jac/14.2.105 Oyeka, 1990, In vitro sensitivity of seven azole compounds against some clinical isolates of non-dermatophytic filamentous fungi and some dermatophytes, Mycopathologia, 11, 157, 10.1007/BF00437540 Somorin, 1977, Dermatophytosis in children, Niger Med J Paed, 4, 39 Egere, 1982, Etiology of dermatophytosis in Eastern Nigeria, Mykosen, 25, 171, 10.1111/j.1439-0507.1982.tb02736.x Obasi, 1985, The treatment of superficial dermatophyte infections with tioconazole in Kaduna, Nigeria, Curr Ther Res, 37, 1062 Kubeyinje, 1985, An open clinical trial of ketoconazole in pityriasis versicolor, Curr Ther Res, 37, 1072 Oyeka, 1992, Comparison of efficacy of isoconazole nitrate versus clotrimazole in foot and nail infections due to dermatophytes, Hendersonula toruloidea and Scytalidium hyalinum, Mycoses, 35, 357, 10.1111/j.1439-0507.1992.tb00894.x